{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:44:23Z","timestamp":1789191863112,"version":"build-2803163510"},"reference-count":344,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","award":["CXTD202102"],"award-info":[{"award-number":["CXTD202102"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460510"],"award-info":[{"award-number":["82460510"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203565"],"award-info":[{"award-number":["82203565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31960145"],"award-info":[{"award-number":["31960145"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103388"],"award-info":[{"award-number":["82103388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960462"],"award-info":[{"award-number":["81960462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117465","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:45:53Z","timestamp":1727189153000},"page":"117465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics"],"prefix":"10.1016","volume":"180","author":[{"given":"Asif","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaoJiao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117465_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/IO9.0000000000000034","article-title":"Renal cell carcinoma: an overview of the epidemiology, presentation, histopathological characteristics, and surgical treatment variation between old and new era\u2013a cross-sectional study","volume":"62","author":"Al Azab","year":"2024","journal-title":"Int. J. Surg. Open"},{"key":"10.1016\/j.biopha.2024.117465_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","author":"Cirillo","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biopha.2024.117465_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgr.2024.03.004","article-title":"Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides","author":"Nguyen","year":"2024","journal-title":"J. Ginseng Res."},{"key":"10.1016\/j.biopha.2024.117465_bib4","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: a Cancer J. Clin."},{"key":"10.1016\/j.biopha.2024.117465_bib5","series-title":"Urologic Oncology: Seminars and Original Investigations","article-title":"Differences in cancer presentation, treatment, and mortality between rural and urban patients diagnosed with kidney cancer in the united states","author":"Connors","year":"2024"},{"key":"10.1016\/j.biopha.2024.117465_bib6","article-title":"Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study. Contemporary Oncology\/","volume":"27","author":"Doma\u0144ski","year":"2024","journal-title":"Wsp\u00f3\u0142czesna Onkol."},{"key":"10.1016\/j.biopha.2024.117465_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-023-01911-x","article-title":"Evolution of cell therapy for renal cell carcinoma","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/cancers16061209","article-title":"Current treatment options for renal cell carcinoma: focus on cell-based immunotherapy","volume":"16","author":"Hwang","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117465_bib9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/09205063.2022.2054399","article-title":"Recent advances in nanotechnology based combination drug therapy for skin cancer","volume":"33","author":"Kumari","year":"2022","journal-title":"J. Biomater. Sci.\u00a0Polym. Ed."},{"key":"10.1016\/j.biopha.2024.117465_bib10","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/pharmaceutics15031025","article-title":"Nanotechnology in cancer diagnosis and treatment","volume":"15","author":"Alrushaid","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101512","article-title":"Nanoparticle-based medicines in clinical cancer therapy","volume":"45","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2024.117465_bib12","first-page":"1","article-title":"Advances in delivery of chemotherapeutic agents for cancer treatment","volume":"23","author":"Yadav","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2024.117465_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmaceutics14010106","article-title":"Development of pharmaceutical nanomedicines: from the bench to the market","volume":"14","author":"Halwani","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09403","article-title":"Lipid-based nanoparticles for treatment of cancer","volume":"8","author":"Sheoran","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2024.117465_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/ma15020682","article-title":"Synthesis and potential applications of lipid nanoparticles in medicine","volume":"15","author":"Musielak","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.biopha.2024.117465_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.biopha.2024.117465_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2023.07.054","article-title":"Lipid nanoparticles for sirna delivery in cancer treatment","volume":"361","author":"El Moukhtari","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102871","article-title":"Lipid-core nanoparticles: classification, preparation methods, routes of administration and recent advances in cancer treatment","volume":"314","author":"Grav\u00e1n","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib19","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s13204-021-02018-9","article-title":"Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment","volume":"12","author":"Hussein","year":"2022","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.biopha.2024.117465_bib20","article-title":"Lipid nanoparticle-based mrna vaccines in cancers: current advances and future prospects","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117465_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/pharmaceutics15010216","article-title":"Lipid nanoparticles functionalized with antibodies for anticancer drug therapy","volume":"15","author":"Marques","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/pharmaceutics13060840","article-title":"Recent progress in lipid nanoparticles for cancer theranostics: opportunity and challenges","volume":"13","author":"Bukhari","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/pharmaceutics13040549","article-title":"Challenges in the physical characterization of lipid nanoparticles","volume":"13","author":"Hallan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for rna delivery","volume":"55","author":"Eygeris","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib25","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1021\/acs.accounts.1c00550","article-title":"Lipid nanoparticle\u2013mrna formulations for therapeutic applications","volume":"54","author":"Wang","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203033","article-title":"High-precision synthesis of rna-loaded lipid nanoparticles for biomedical applications","volume":"12","author":"Seo","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib27","article-title":"Theranostic lipid nanoparticles for renal cell carcinoma","author":"Mao","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib28","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117465_bib29","article-title":"Application of lipid-based nanoparticles in cancer immunotherapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117465_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40005-022-00569-9","article-title":"Recent advancements in lipid\u2013mrna nanoparticles as a treatment option for cancer immunotherapy","volume":"52","author":"Karmacharya","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.biopha.2024.117465_bib31","first-page":"62","article-title":"Lipid-based nanoparticles (lnp) structures used for drug delivery and targeting: Clinical trials and patents","volume":"13","author":"Amarachi Chime","year":"2023","journal-title":"Nanosci. Nanotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib32","doi-asserted-by":"crossref","first-page":"10068","DOI":"10.3390\/ijms231710068","article-title":"Lipid-based nanoparticles as a pivotal delivery approach in triple negative breast cancer (tnbc) therapy","volume":"23","author":"Chaudhuri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/pharmaceutics15030831","article-title":"Solid lipid nanoparticles: multitasking nano-carriers for cancer treatment","volume":"15","author":"German-Cort\u00e9s","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib34","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500 from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib35","article-title":"Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application","volume":"1865","author":"Rizwanullah","year":"2021","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.biopha.2024.117465_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43094-022-00414-8","article-title":"Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours","volume":"8","author":"Garg","year":"2022","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2021.05.003","article-title":"Methods for preparation of nanostructured lipid carriers","volume":"199","author":"Gomaa","year":"2022","journal-title":"Methods"},{"key":"10.1016\/j.biopha.2024.117465_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.fhfh.2022.100054","article-title":"Recent advances in lipid-protein conjugate-based delivery systems in nutraceutical, drug, and gene delivery","volume":"2","author":"Dissanayake","year":"2022","journal-title":"Food Hydrocoll. Health"},{"key":"10.1016\/j.biopha.2024.117465_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijbiomac.2022.12.087","article-title":"Current nanotechnological strategies using lipids, carbohydrates, proteins and metal conjugates-based carrier systems for diagnosis and treatment of tuberculosis\u2014a review","volume":"227","author":"Usharani","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.117465_bib40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.addr.2021.04.003","article-title":"Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis","volume":"173","author":"Salunkhe","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117465_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/pharmaceutics14030600","article-title":"Development, therapeutic evaluation and theranostic applications of cubosomes on cancers: an updated review","volume":"14","author":"Almoshari","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.apsb.2021.02.013","article-title":"Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles","volume":"11","author":"Yaghmur","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.117465_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117145","article-title":"Lipid shell lipid nanocapsules as smart generation lipid nanocarriers","volume":"339","author":"Dabholkar","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.biopha.2024.117465_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.59049\/2790-0231.1244","article-title":"An overview of nanocapsule and lipid nanocapsule: recent developments and future prospects","volume":"8","author":"Elmarzugi","year":"2023","journal-title":"Palest. Med. Pharm. J."},{"key":"10.1016\/j.biopha.2024.117465_bib45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/10717544.2021.1917728","article-title":"Enhancing the in vitro and in vivo activity of itraconazole against breast cancer using miltefosine-modified lipid nanocapsules","volume":"28","author":"El-Sheridy","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib46","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/pharmaceutics15071989","article-title":"Nano-and microemulsions in biomedicine: from theory to practice","volume":"15","author":"Nikolaev","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/bioengineering9040158","article-title":"Microemulsions and nanoemulsions in skin drug delivery","volume":"9","author":"Souto","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.biopha.2024.117465_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jconrel.2022.09.035","article-title":"Nanoemulsion applications in photodynamic therapy","volume":"351","author":"Moghassemi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib49","first-page":"113","article-title":"Emulsomes: a lipid bases drug delivery system","volume":"10","author":"Gill","year":"2021","journal-title":"World J. Pharm. Res"},{"key":"10.1016\/j.biopha.2024.117465_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5530\/ijper.55.1.12","article-title":"Preparation and evaluation of emulsomes as a drug delivery system for bifonazole","volume":"55","author":"Malviya","year":"2021","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib51","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jconrel.2022.10.002","article-title":"Glycosylation of ova antigen-loaded plga nanoparticles enhances dc-targeting for cancer vaccination","volume":"351","author":"Chou","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib52","article-title":"University of Babylon","author":"Abass","year":"2023","journal-title":"Drug Load. cuo Nanopart. Synth. Chem. Method"},{"key":"10.1016\/j.biopha.2024.117465_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2021.10.025","article-title":"Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting","volume":"340","author":"Handa","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s11671-021-03553-8","article-title":"Liposomal nanomedicine: applications for drug delivery in cancer therapy","volume":"16","author":"Rommasi","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.biopha.2024.117465_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery system for therapeutic applications","volume":"601","author":"Guimar\u00e3es","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4068\/cmj.2021.57.1.27","article-title":"Liposomes: biomedical applications","volume":"57","author":"Kim","year":"2021","journal-title":"Chonnam Med. J."},{"key":"10.1016\/j.biopha.2024.117465_bib57","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.3390\/ijms24076615","article-title":"Liposomes in cancer therapy: how did we start and where are we now","volume":"24","author":"Fulton","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/08982104.2021.2019762","article-title":"A drift on liposomes to proliposomes: recent advances and promising approaches","volume":"32","author":"Dhiman","year":"2022","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2024.117465_bib59","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2147\/IJN.S306831","article-title":"Design and characterization of spray-dried proliposomes for the pulmonary delivery of curcumin","author":"Adel","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib60","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2217\/nnm-2021-0335","article-title":"Transfersomes as alternative topical nanodosage forms for the treatment of skin disorders","volume":"16","author":"Oyarz\u00fan","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117465_bib61","first-page":"1","article-title":"Transfersomes: a revolutionary nanosystem for efficient transdermal drug delivery","volume":"23","author":"Akram","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2024.117465_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4155\/tde-2020-0122","article-title":"Liposomes and transferosomes: a breakthrough in topical and transdermal delivery","volume":"12","author":"Sapkota","year":"2021","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib63","article-title":"Invasomes: potential vesicular systems for transdermal delivery of drug molecules","volume":"61","author":"Jain","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2024.117465_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100058","article-title":"Formulation, characterization and ex vivo study of curcumin nano-invasomal gel for enhanced transdermal delivery","volume":"7","author":"Kumar","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.biopha.2024.117465_bib65","first-page":"186","article-title":"A comprehensive review on preparation, evaluation and applications of deformable liposomes","volume":"20","author":"Nayak","year":"2021","journal-title":"Iran. J. Pharm. Res.: IJPR"},{"key":"10.1016\/j.biopha.2024.117465_bib66","doi-asserted-by":"crossref","first-page":"427","DOI":"10.30574\/wjbphs.2024.17.2.0084","article-title":"Invasomes: a vesicular carrier for transdermal delivery","volume":"17","author":"Sarangamath","year":"2024","journal-title":"World J. Biol. Pharm. Health Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib67","article-title":"Penetration enhancer containing vesicles for dermal and transdermal drug delivery. A review","author":"Sarhan","year":"2023","journal-title":"Arch. Pharm. Sci. Ain Shams Univ."},{"key":"10.1016\/j.biopha.2024.117465_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2011.03.068","article-title":"Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin","volume":"412","author":"Manconi","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111262","article-title":"Lipid vesicles: a versatile drug delivery platform for dermal and transdermal applications","volume":"195","author":"Chacko","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s13402-014-0183-7","article-title":"Apoptosis induction and anti-cancer activity of leciplex formulations","volume":"37","author":"Dhawan","year":"2014","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.biopha.2024.117465_bib71","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2217\/nnm.11.38","article-title":"Lecithin-based novel cationic nanocarriers (leciplex) i: fabrication, characterization and evaluation","volume":"6","author":"Date","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117465_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijpharm.2015.05.042","article-title":"Leciplex, invasomes, and liposomes: a skin penetration study","volume":"490","author":"Shah","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12645-021-00085-9","article-title":"Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect","volume":"12","author":"Dabbagh Moghaddam","year":"2021","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib74","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/pharmaceutics13030394","article-title":"In-vitro application of magnetic hybrid niosomes: targeted sirna-delivery for enhanced breast cancer therapy","volume":"13","author":"Maurer","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib75","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12032-022-01836-3","article-title":"Niosomes: a novel targeted drug delivery system for cancer","volume":"39","author":"Moghtaderi","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2024.117465_bib76","article-title":"Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: fabrication and cytotoxic studies against breast cancer cell lines","volume":"65","author":"Alaaeldin","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2024.117465_bib77","first-page":"4684","article-title":"The future of non-invasive ways to treat cancer","volume":"12","author":"Imam","year":"2021","journal-title":"Int J. Pharm. Sci. Res2021"},{"key":"10.1016\/j.biopha.2024.117465_bib78","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1208\/s12249-022-02217-9","article-title":"Spanlastics a novel nanovesicular carrier: its potential application and emerging trends in therapeutic delivery","volume":"23","author":"Ansari","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2024.117465_bib79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijpharm.2014.06.048","article-title":"Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: In-vitro and in-vivo characterization","volume":"472","author":"ElKasabgy","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.fjps.2017.02.001","article-title":"Pharmaceutical significance of eudragit: a review","volume":"3","author":"Patra","year":"2017","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/10717544.2016.1255999","article-title":"Nanocarriers as treatment modalities for hypertension","volume":"24","author":"Alam","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib82","first-page":"1399","article-title":"Pharmaceutical approach for treatment of chronic disease: hypertension by chronotherapy","volume":"22","author":"Chaurasiya","year":"2019","journal-title":"Think. India J."},{"key":"10.1016\/j.biopha.2024.117465_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2022.102561","article-title":"Diversifying the skin cancer-fighting worthwhile frontiers: how relevant are the itraconazole\/ascorbyl palmitate nanovectors?","volume":"43","author":"Lamie","year":"2022","journal-title":"Nanomed.: Nanotechnol.\u00a0Biol. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119092","article-title":"Cosm-nutraceutical nanovesicles for acne treatment: Physicochemical characterization and exploratory clinical experimentation","volume":"577","author":"Amer","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.22270\/jddt.v9i1-s.2234","article-title":"An updated review on pharmacosomes, a vesicular drug delivery system","volume":"9","author":"Supraja","year":"2019","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.biopha.2024.117465_bib86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cis.2018.01.003","article-title":"Prodrugs, phospholipids and vesicular delivery-an effective triumvirate of pharmacosomes","volume":"253","author":"Kapoor","year":"2018","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib87","first-page":"94","article-title":"Pharmacosomes: a novel drug delivery system","volume":"3","author":"Sharma","year":"2014","journal-title":"Pharma Innov."},{"key":"10.1016\/j.biopha.2024.117465_bib88","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3329\/icpj.v1i11.12065","article-title":"Solid lipid nanoparticles (sln): method, characterization and applications","volume":"1","author":"Garud","year":"2012","journal-title":"Int Curr. Pharm. J."},{"key":"10.1016\/j.biopha.2024.117465_bib89","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/nano9030474","article-title":"Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs","volume":"9","author":"Bay\u00f3n-Cordero","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib90","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.3390\/ijms24076199","article-title":"Solid lipid nanoparticles: applications and prospects in cancer treatment","volume":"24","author":"Sivadasan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.18433\/jpps31788","article-title":"Solid lipid nanoparticles: an approach to improve oral drug delivery","volume":"24","author":"Mendoza-Munoz","year":"2021","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib92","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","article-title":"Nanostructured lipid carriers (nlcs) as drug delivery platform: advances in formulation and delivery strategies","volume":"29","author":"Elmowafy","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2024.117465_bib93","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08982104.2023.2204372","article-title":"A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials","volume":"34","author":"Kabil","year":"2024","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2024.117465_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/molecules29010031","article-title":"Optimized dox drug deliveries via chitosan-mediated nanoparticles and stimuli responses in cancer chemotherapy: a review","volume":"29","author":"Imran","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117465_bib95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcis.2022.04.031","article-title":"Potential of curcumin-loaded cubosomes for topical treatment of cervical cancer","volume":"620","author":"Victorelli","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2021.100561","article-title":"Cubosomes in cancer drug delivery: a review","volume":"46","author":"Varghese","year":"2022","journal-title":"Colloid Interface Sci. Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120217","article-title":"Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells","volume":"597","author":"Valsalakumari","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.753947","article-title":"Microemulsion based nanostructures for drug delivery","volume":"3","author":"Arredondo-Ochoa","year":"2022","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib99","article-title":"A judicious review on the applications of chemotherapeutic loaded nanoemulsions in cancer management","volume":"68","author":"Alshahrani","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2024.117465_bib100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s43094-023-00530-z","article-title":"Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport","volume":"9","author":"Singh","year":"2023","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib101","doi-asserted-by":"crossref","DOI":"10.1088\/2632-959X\/abeb4b","article-title":"Lipid-polymer hybrid nanoparticles in cancer therapy: current overview and future directions","volume":"2","author":"Persano","year":"2021","journal-title":"Nano Express"},{"key":"10.1016\/j.biopha.2024.117465_bib102","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/pharmaceutics13081291","article-title":"Polymeric lipid hybrid nanoparticles (plns) as emerging drug delivery platform\u2014a comprehensive review of their properties, preparation methods, and therapeutic applications","volume":"13","author":"Sivadasan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib103","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.xphs.2021.04.006","article-title":"Polymeric lipid hybrid nanoparticles as a delivery system enhance the antitumor effect of emodin in vitro and in vivo","volume":"110","author":"Liu","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib104","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/biomedicines10020283","article-title":"Lipid-based nanocarriers in renal rna therapy","volume":"10","author":"Su","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.117465_bib105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/ijms23010131","article-title":"The application of nanoparticles in diagnosis and treatment of kidney diseases","volume":"23","author":"Paluszkiewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib106","first-page":"206","article-title":"Targeted therapy of kidney disease with nanoparticle drug delivery materials","volume":"37","author":"Shang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib107","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00467-021-05352-w","article-title":"The potential of rna-based therapy for kidney diseases","volume":"38","author":"Bondue","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.biopha.2024.117465_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202370021","article-title":"Advanced nanomaterials for the diagnosis and treatment of renal cell carcinoma","volume":"3","author":"Ji","year":"2023","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.biopha.2024.117465_bib109","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.2147\/IJN.S265061","article-title":"At101-loaded cubosomes as an alternative for improved glioblastoma therapy","author":"Flak","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib110","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ijpharm.2015.09.062","article-title":"Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and cpg-odn in the treatment of glioblastoma","volume":"495","author":"Lollo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib111","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2217\/nnm-2018-0196","article-title":"Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined cox-2 inhibitor\/herbal therapy of breast cancer","volume":"13","author":"AbdElhamid","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117465_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112189","article-title":"Arginine-tocopherol bioconjugated lipid vesicles for selective ptrail delivery and subsequent apoptosis induction in glioblastoma cells","volume":"126","author":"Ravula","year":"2021","journal-title":"Mater. Sci. Eng.: C."},{"key":"10.1016\/j.biopha.2024.117465_bib113","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1021\/acs.molpharmaceut.9b00738","article-title":"A multifunctional lipid-based nanodevice for the highly specific codelivery of sorafenib and midkine sirna to hepatic cancer cells","volume":"16","author":"Younis","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib114","doi-asserted-by":"crossref","first-page":"85261","DOI":"10.1039\/C6RA16426A","article-title":"Lipid nanocarrier-based transport of docetaxel across the blood brain barrier","volume":"6","author":"Satapathy","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2024.117465_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5582\/ddt.2015.01016","article-title":"Liposome encapsulated of temozolomide for the treatment of glioma tumor: preparation, characterization and evaluation","volume":"9","author":"Gao","year":"2015","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.biopha.2024.117465_bib116","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2015.08.022","article-title":"Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma","volume":"369","author":"Kim","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.117465_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04315-4","article-title":"Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles","volume":"9","author":"Lam","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117465_bib119","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.2147\/IJN.S131367","article-title":"A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood\u2013brain barrier, and the transporting mechanism to glioma cells","author":"Liu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijpharm.2018.05.007","article-title":"Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma","volume":"545","author":"Cheng","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib121","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10717544.2013.801047","article-title":"In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice","volume":"20","author":"Jin","year":"2013","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib122","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejpb.2015.03.003","article-title":"Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice","volume":"93","author":"Zhao","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2024.117465_bib123","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.3390\/ijms150915287","article-title":"Dual targeting biomimetic liposomes for paclitaxel\/DNA combination cancer treatment","volume":"15","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib124","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jamp.2011-0966","article-title":"Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice","volume":"26","author":"Mainelis","year":"2013","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42003-020-1016-z","article-title":"Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy","volume":"3","author":"Prasad","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2024.117465_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105576","article-title":"Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer","volume":"156","author":"Karpuz","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib127","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.7150\/thno.42234","article-title":"Bbb-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with egfrt790m mutation","volume":"10","author":"Yin","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.117465_bib128","doi-asserted-by":"crossref","first-page":"15567","DOI":"10.1021\/acsomega.9b01924","article-title":"Nanobubble liposome complexes for diagnostic imaging and ultrasound-triggered drug delivery in cancers: a theranostic approach","volume":"4","author":"Prabhakar","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2024.117465_bib129","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1016\/j.biomaterials.2011.03.067","article-title":"Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy","volume":"32","author":"Kwong","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111774","article-title":"Tailoring functional nanostructured lipid carriers for glioblastoma treatment with enhanced permeability through in-vitro 3d bbb\/bbtb models","volume":"121","author":"Zwain","year":"2021","journal-title":"Mater. Sci. Eng.: C."},{"key":"10.1016\/j.biopha.2024.117465_bib131","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2147\/IJN.S161163","article-title":"Lactoferrin-and rgd-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib132","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejps.2018.02.024","article-title":"Modeling of ultra-small lipid nanoparticle surface charge for targeting glioblastoma","volume":"117","author":"Mendes","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib133","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1080\/10717544.2016.1217954","article-title":"Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors","volume":"23","author":"Jiang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib134","first-page":"585","article-title":"Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery","volume":"65","author":"Hu","year":"2010","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib135","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.nano.2011.12.007","article-title":"Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect","volume":"8","author":"Videira","year":"2012","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib136","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/wjtcm.wjtcm_2_20","article-title":"Nanocarriers to enhance solubility, bioavailability, and efficacy of artemisinins","volume":"6","author":"Bilia","year":"2020","journal-title":"World J. Tradit. Chin. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib137","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2015.12.054","article-title":"Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation","volume":"499","author":"Kuo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib138","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jtice.2015.12.012","article-title":"Delivery of doxorubicin to glioblastoma multiforme in vitro using solid lipid nanoparticles with surface aprotinin and melanotransferrin antibody for enhanced chemotherapy","volume":"61","author":"Kuo","year":"2016","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.biopha.2024.117465_bib139","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2147\/IJN.S161237","article-title":"Enhanced permeability of blood\u2013brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle","author":"Song","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/nnm-2018-0436","article-title":"Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment","volume":"8","author":"Grillone","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117465_bib141","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actbio.2016.04.026","article-title":"Paclitaxel-loaded solid lipid nanoparticles modified with tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy","volume":"38","author":"Banerjee","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2024.117465_bib142","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijpharm.2016.01.018","article-title":"Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles","volume":"500","author":"Garanti","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib143","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jps.24002","article-title":"Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies","volume":"103","author":"Battaglia","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib144","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejpb.2014.10.017","article-title":"Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment","volume":"88","author":"Chirio","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2024.117465_bib145","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib146","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/jps.24388","article-title":"Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with \u03c1-aminophenyl-\u03b1-d-manno-pyranoside and folic acid","volume":"104","author":"Kuo","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"40","key":"10.1016\/j.biopha.2024.117465_bib147","doi-asserted-by":"crossref","first-page":"15434","DOI":"10.1039\/C7NR05216B","article-title":"Enhanced blood brain barrier permeability and glioblastoma cell targeting via thermoresponsive lipid nanoparticles","volume":"9","author":"Rehman","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117465_bib148","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/03639045.2017.1391835","article-title":"Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and mir-21 antisense oligonucleotide to glioblastoma cells","volume":"44","author":"K\u00fc\u00e7\u00fckt\u00fcrkmen","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib149","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jtice.2017.04.026","article-title":"Anti-melanotransferrin and apolipoprotein e on doxorubicin-loaded cationic solid lipid nanoparticles for pharmacotherapy of glioblastoma multiforme","volume":"77","author":"Kuo","year":"2017","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.biopha.2024.117465_bib150","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2217\/nnm-2020-0035","article-title":"Rgd-decorated solid lipid nanoparticles enhance tumor targeting, penetration and anticancer effect of asiatic acid","volume":"15","author":"Garanti","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2024.117465_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111461","article-title":"Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme","volume":"138","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117465_bib152","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/21691401.2018.1472101","article-title":"Co-delivery of paclitaxel and tanespimycin in lipid nanoparticles enhanced anti-gastric-tumor effect in vitro and in vivo","volume":"46","author":"Ma","year":"2018","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib153","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fbioe.2020.00879","article-title":"Enhancing bioavailability and stability of curcumin using solid lipid nanoparticles (clen): a covenant for its effectiveness","volume":"8","author":"Gupta","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib154","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.2147\/IJN.S64103","article-title":"Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway","author":"Wang","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib155","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s11095-017-2202-7","article-title":"Mir-542-3p appended sorafenib\/all-trans retinoic acid (atra)-loaded lipid nanoparticles to enhance the anticancer efficacy in gastric cancers","volume":"34","author":"Li","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib156","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/08982104.2013.868476","article-title":"Comparing different sterol containing solid lipid nanoparticles for targeted delivery of quercetin in hepatocellular carcinoma","volume":"24","author":"Varshosaz","year":"2014","journal-title":"J. liposome Res."},{"key":"10.1016\/j.biopha.2024.117465_bib157","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/molecules22111814","article-title":"Anticancer effects of resveratrol-loaded solid lipid nanoparticles on human breast cancer cells","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117465_bib158","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.2147\/IJN.S182621","article-title":"Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells","author":"Xu","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib159","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.2147\/IJN.S111647","article-title":"Microrna-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell","author":"Liu","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/nano8030159","article-title":"Sustained cytotoxicity of wogonin on breast cancer cells by encapsulation in solid lipid nanoparticles","volume":"8","author":"Baek","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib161","article-title":"Solid lipid nanoparticles: reversal of tamoxifen resistance in breast cancer","author":"Eskiler","year":"2018","journal-title":"G\u00fcney"},{"key":"10.1016\/j.biopha.2024.117465_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109006","article-title":"Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, ph sensitive lipid and evaluation of the nanomedicine in vitro and in vivo","volume":"116","author":"Zheng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117465_bib163","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/10837450.2019.1703739","article-title":"Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment","volume":"25","author":"Yassemi","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.biopha.2024.117465_bib164","article-title":"Development of novel s pc-3 gefitinib lipid nanoparticles for effective drug delivery in breast cancer. Tissue distribution studies and cell cytotoxicity analysis","volume":"61","author":"Nayek","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2024.117465_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121044","article-title":"Mitoxantrone-loaded lipid nanoparticles for breast cancer therapy\u2013quality-by-design approach and efficacy assessment in 2d and 3d in vitro cancer models","volume":"607","author":"Granja","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib166","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/nano10030510","article-title":"Rapid microwave-assisted cisplatin-loaded solid lipid nanoparticles: synthesis, characterization and anticancer study","volume":"10","author":"Aldawsari","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib167","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1039\/c3tb20990c","article-title":"Recent trends in the use of lipidic nanoparticles as pharmaceutical carriers for cancer therapy and diagnostics","volume":"1","author":"Mussi","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2024.117465_bib168","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/bc100478k","article-title":"Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging","volume":"22","author":"Andreozzi","year":"2011","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.biopha.2024.117465_bib169","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7150\/thno.29820","article-title":"Gsh-sensitive pt (iv) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer","volume":"9","author":"Huang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.117465_bib170","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/acs.accounts.0c00323","article-title":"Nanomedicines for renal management: from imaging to treatment","volume":"53","author":"Jiang","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib171","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrneph.2016.156","article-title":"Nanomedicines for renal disease: current status and future applications","volume":"12","author":"Kamaly","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2024.117465_bib172","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10173","article-title":"The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles","volume":"5","author":"Huang","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib173","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","article-title":"The glomerular filtration barrier: a structural target for novel kidney therapies","volume":"20","author":"Daehn","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.117465_bib174","article-title":"Facile fabrication of quaternized chitosan-incorporated biomolecular patches for non-compressive haemostasis and wound healing","author":"Chen","year":"2023","journal-title":"Fundam. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions","volume":"334","author":"Huang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib176","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1039\/D1NR06580G","article-title":"Nanoparticle protein corona evolution: from biological impact to biomarker discovery","volume":"14","author":"Kamaly","year":"2022","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117465_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit. care"},{"key":"10.1016\/j.biopha.2024.117465_bib178","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.yexcr.2012.02.031","article-title":"The glomerular basement membrane","volume":"318","author":"Miner","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2024.117465_bib179","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/pharmaceutics15041184","article-title":"Key design features of lipid nanoparticles and electrostatic charge-based lipid nanoparticle targeting","volume":"15","author":"Gyanani","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib180","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2020.06.029","article-title":"Human intratumoral therapy: linking drug properties and tumor transport of drugs in clinical trials","volume":"326","author":"Huang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib181","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1158\/1078-0432.CCR-20-0472","article-title":"Intratumoral il12 mrna therapy promotes th1 transformation of the tumor microenvironment","volume":"26","author":"Hewitt","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117465_bib182","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/acs.molpharmaceut.0c00451","article-title":"Efficient colorectal cancer gene therapy with il-15 mrna nanoformulation","volume":"17","author":"Lei","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of il-23, il-36\u03b3, and ox40l mrnas","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib184","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s43018-020-0095-6","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating il-12 rna to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib185","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (epr): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng.: C."},{"key":"10.1016\/j.biopha.2024.117465_bib186","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib187","series-title":"Springer seminars in immunopathology","first-page":"339","article-title":"Lotze MT. Th1\/th2 balance in cancer, transplantation and pregnancy","author":"Shurin","year":"1999"},{"key":"10.1016\/j.biopha.2024.117465_bib188","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1158\/1538-7445.AM2019-5017","article-title":"Medi1191, a novel il-12 mrna therapy for intratumoral injection to promote th1 transformation of the patient tumor microenvironment","volume":"79","author":"Luheshi","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117465_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0431-x","article-title":"Lipid nanoparticles that deliver il-12 messenger rna suppress tumorigenesis in myc oncogene-driven hepatocellular carcinoma","volume":"6","author":"Lai","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/D1NA00721A","article-title":"Ph-responsive hollow fe\u2013gallic acid coordination polymer for multimodal synergistic-therapy and mri of cancer","volume":"4","author":"Liu","year":"2022","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.biopha.2024.117465_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121339","article-title":"In situ t-cell transfection by anti-cd3-conjugated lipid nanoparticles leads to t-cell activation, migration, and phenotypic shift","volume":"281","author":"Kheirolomoom","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-019-2684-6","article-title":"Dual-targeted delivery of nanoparticles encapsulating paclitaxel and everolimus: a novel strategy to overcome breast cancer receptor heterogeneity","volume":"37","author":"Houdaihed","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib193","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.09.074","article-title":"Drug targeting and tumor heterogeneity","volume":"133","author":"Bae","year":"2009","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2024.117465_bib194","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2012.05.052","article-title":"Challenges in design and characterization of ligand-targeted drug delivery systems","volume":"164","author":"Muro","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib195","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-06-0250","article-title":"C-met ectodomain shedding rate correlates with malignant potential","volume":"12","author":"Athauda","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117465_bib196","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41416-023-02287-x","article-title":"Anticipating changes in the her2 status of breast tumours with disease progression\u2014towards better treatment decisions in the new era of her2-low breast cancers","volume":"129","author":"Bergeron","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2019.104032","article-title":"Intracellular rna delivery by lipid nanoparticles: diffusion, degradation, and release","volume":"185","author":"Zhdanov","year":"2019","journal-title":"Biosystems"},{"key":"10.1016\/j.biopha.2024.117465_bib198","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s11095-014-1366-7","article-title":"Insight into mechanisms of cellular uptake of lipid nanoparticles and intracellular release of small rnas","volume":"31","author":"Yu","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib199","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.117465_bib200","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1389201024666230403094238","article-title":"Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging","volume":"25","author":"Bailey-Hytholt","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib201","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2020.09.007","article-title":"Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine","volume":"327","author":"Yamada","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1014428720551","article-title":"Phase ii trial of pegylated-liposomal doxorubicin (doxil\u2122) in renal cell cancer","volume":"20","author":"Skubitz","year":"2002","journal-title":"Investig. N. Drugs"},{"key":"10.1016\/j.biopha.2024.117465_bib203","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.2147\/IJN.S204221","article-title":"Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in rcc","author":"Pal","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2024.117465_bib204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2012.06.019","article-title":"Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy","volume":"162","author":"Takara","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib205","first-page":"1441","article-title":"Significant induction of apoptosis in renal cell carcinoma cells transfected with cationic multilamellar liposomes containing the human interferon-\u03b2 gene through activation of the intracellular type 1 interferon signal pathway","volume":"40","author":"Takaha","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2024.117465_bib206","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.xphs.2017.01.027","article-title":"Focused ultrasound\u2013triggered release of tyrosine kinase inhibitor from thermosensitive liposomes for treatment of renal cell carcinoma","volume":"106","author":"Abshire","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib207","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cbdd.13652","article-title":"Sertraline\/icg-loaded liposome for dual-modality imaging and effective chemo-photothermal combination therapy against metastatic clear cell renal cell carcinoma.","volume":"95","author":"Lei","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2024.117465_bib208","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.nano.2016.04.002","article-title":"Sustained inhibition of cmet-vegfr2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer","volume":"12","author":"Kulkarni","year":"2016","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib209","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2014.12.029","article-title":"A neutral lipid envelope-type nanoparticle composed of a ph-activated and vitamin e-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma","volume":"200","author":"Akita","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib210","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.bjc.6602526","article-title":"Induction of effective and antigen-specific antitumour immunity by a liposomal erbb2\/her2 peptide-based vaccination construct","volume":"92","author":"Roth","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib211","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/jps.24318","article-title":"Comparison of sorafenib-loaded poly (lactic\/glycolic) acid and dppc liposome nanoparticles in the in vitro treatment of renal cell carcinoma","volume":"104","author":"Liu","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib212","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.biomaterials.2018.08.053","article-title":"Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages","volume":"183","author":"Alsaab","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib213","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1021\/acsnano.9b00467","article-title":"Carrier-enhanced anticancer efficacy of sunitinib-loaded green tea-based micellar nanocomplex beyond tumor-targeted delivery","volume":"13","author":"Yongvongsoontorn","year":"2019","journal-title":"Acs Nano"},{"key":"10.1016\/j.biopha.2024.117465_bib214","doi-asserted-by":"crossref","DOI":"10.1038\/537S98a","article-title":"The silent disease","volume":"537","author":"Shaw","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117465_bib215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-12-0429","article-title":"First-in-humans trial of an rna interference therapeutic targeting vegf and ksp in cancer patients with liver involvement","volume":"3","author":"Tabernero","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2024.117465_bib216","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003101","article-title":"Immunization with short peptide particles reveals a functional cd8+ t-cell neoepitope in a murine renal carcinoma model","volume":"9","author":"He","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114417","article-title":"Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines","volume":"188","author":"Nakamura","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117465_bib218","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1021\/acsami.8b21398","article-title":"Lipid-mrna nanoparticle designed to enhance intracellular delivery mediated by shock waves","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10601","article-title":"A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumors","volume":"9","author":"Paun","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2024.117465_bib221","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/1389200216666150812122128","article-title":"Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics","volume":"16","author":"Ahmad","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2024.117465_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112520","article-title":"Fabrication, physicochemical characterization and in vitro anticancer activity of nerolidol encapsulated solid lipid nanoparticles in human colorectal cell line","volume":"215","author":"Parvez","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib223","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1191731","article-title":"Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma","volume":"5","author":"Penny","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2024.117465_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111029","article-title":"Ph-responsive cascaded nanocatalyst for synergistic like-starvation and chemodynamic therapy","volume":"192","author":"Wang","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib225","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1021\/jacs.1c03303","article-title":"Highly stable silica-coated bismuth nanoparticles deliver tumor microenvironment-responsive prodrugs to enhance tumor-specific photoradiotherapy","volume":"143","author":"Xiang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2024.117465_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119463","article-title":"Multivalency-assisted membrane-penetrating sirna delivery sensitizes photothermal ablation via inhibition of tumor glycolysis metabolism","volume":"223","author":"Dang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib227","article-title":"Triple-jump photodynamic theranostics: Mno2 combined upconversion nanoplatforms involving a type-i photosensitizer with aggregation-induced emission characteristics for potent cancer treatment","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib228","article-title":"Engineering a hydrogen-sulfide-based nanomodulator to normalize hyperactive photothermal immunogenicity for combination cancer therapy","volume":"33","author":"Li","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib229","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1002\/anie.202015082","article-title":"Photogenerated holes mediated nitric oxide production for hypoxic tumor treatment","volume":"60","author":"Fang","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.117465_bib230","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101467","article-title":"A robust narrow bandgap vanadium tetrasulfide sonosensitizer optimized by charge separation engineering for enhanced sonodynamic cancer therapy","volume":"33","author":"Liang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.01.002","article-title":"Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting cox-2 pathway and glut-1 receptors to prevent prostate cancer cell proliferation","volume":"448","author":"Tian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.117465_bib232","doi-asserted-by":"crossref","first-page":"22308","DOI":"10.1021\/acsami.7b06582","article-title":"Mussel-inspired hyaluronic acid derivative nanostructures for improved tumor targeting and penetration","volume":"9","author":"Lee","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib233","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acsnano.6b06658","article-title":"Overcoming the heat endurance of tumor cells by interfering with the anaerobic glycolysis metabolism for improved photothermal therapy","volume":"11","author":"Chen","year":"2017","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib234","article-title":"A \u201cvalve-closing\u201d starvation strategy for amplification of tumor-specific chemotherapy","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101200","article-title":"Sugar-originated carbon nanodots selectively damage the tumor and enhance the sensitivity of chemotherapy","volume":"38","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2024.117465_bib236","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/acs.nanolett.0c04520","article-title":"Uncovering the metabolic origin of aspartate for tumor growth using an integrated molecular deactivator","volume":"21","author":"Duan","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2024.117465_bib237","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201516","article-title":"Targeted drug\/gene\/photodynamic therapy via a stimuli-responsive dendritic-polymer-based nanococktail for treatment of egfr-tki-resistant non-small-cell lung cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib238","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801694","article-title":"Perfluorocarbon nanoparticles mediated platelet blocking disrupt vascular barriers to improve the efficacy of oxygen-sensitive antitumor drugs","volume":"14","author":"Zhou","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.biopha.2024.117465_bib239","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41467-022-29082-1","article-title":"In vivo three-dimensional multispectral photoacoustic imaging of dual enzyme-driven cyclic cascade reaction for tumor catalytic therapy","volume":"13","author":"Lei","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121533","article-title":"A sub-6 nm mnfe2o4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment and boosting immunotherapy","volume":"284","author":"Dai","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib241","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.1039\/D0TB00529K","article-title":"A multifunctional oxygen-producing mno 2-based nanoplatform for tumor microenvironment-activated imaging and combination therapy in vitro","volume":"8","author":"Yang","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2024.117465_bib242","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1021\/acsnano.8b02977","article-title":"Normalizing tumor microenvironment based on photosynthetic abiotic\/biotic nanoparticles","volume":"12","author":"Zheng","year":"2018","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib243","doi-asserted-by":"crossref","first-page":"57757","DOI":"10.1021\/acsami.0c18361","article-title":"Click-nucleic-acid-containing codelivery system inducing collapse of cellular homeostasis for tumor therapy through bidirectional regulation of autophagy and glycolysis","volume":"12","author":"Guo","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00720-4","article-title":"Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib245","doi-asserted-by":"crossref","first-page":"50734","DOI":"10.1021\/acsami.0c14909","article-title":"Multifunctional nanoparticles boost cancer immunotherapy based on modulating the immunosuppressive tumor microenvironment","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib246","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jconrel.2021.05.034","article-title":"Redox-responsive nanoassembly restrained myeloid-derived suppressor cells recruitment through autophagy-involved lactate dehydrogenase a silencing for enhanced cancer immunochemotherapy","volume":"335","author":"Xia","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib247","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41467-022-29284-7","article-title":"A hydrogen sulphide-responsive and depleting nanoplatform for cancer photodynamic therapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib248","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1021\/acsnano.9b10037","article-title":"Metabolic modulation of the tumor microenvironment leads to multiple checkpoint inhibition and immune cell infiltration","volume":"14","author":"Kolb","year":"2020","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120631","article-title":"Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis","volume":"269","author":"Islam","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12645-022-00129-8","article-title":"Retro-inversion follicle-stimulating hormone peptide-modified nanoparticles for delivery of pdk2 shrna against chemoresistant ovarian cancer by switching glycolysis to oxidative phosphorylation","volume":"13","author":"Zhang","year":"2022","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib251","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1002\/anie.202002306","article-title":"Tumor-specific chemotherapy by nanomedicine-enabled differential stress sensitization","volume":"59","author":"Yang","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.117465_bib252","doi-asserted-by":"crossref","first-page":"31625","DOI":"10.1021\/acsami.2c05841","article-title":"Nanodrugs incorporating ldha sirna inhibit m2-like polarization of tams and amplify autophagy to assist oxaliplatin chemotherapy against colorectal cancer","volume":"14","author":"Hu","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib253","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","article-title":"Nanoenabled modulation of acidic tumor microenvironment reverses anergy of infiltrating t cells and potentiates anti-pd-1 therapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2024.117465_bib254","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actbio.2022.05.045","article-title":"Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy","volume":"148","author":"Zang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2024.117465_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120935","article-title":"Nir-ii fluorescence imaging guided tumor-specific nir-ii photothermal therapy enhanced by starvation mediated thermal sensitization strategy","volume":"275","author":"Dai","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib256","doi-asserted-by":"crossref","first-page":"22687","DOI":"10.1021\/acsami.0c05763","article-title":"Smart biomimetic nanocomposites mediate mitochondrial outcome through aerobic glycolysis reprogramming: a promising treatment for lymphoma","volume":"12","author":"Zhao","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib257","doi-asserted-by":"crossref","first-page":"56972","DOI":"10.1021\/acsami.1c18053","article-title":"Silencing of pyruvate kinase m2 via a metal\u2013organic framework based theranostic gene nanomedicine for triple-negative breast cancer therapy.","volume":"13","author":"Huang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2024.117465_bib258","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.1021\/acsnano.3c02428","article-title":"Metal-phenolic nanomedicines regulate t-cell antitumor function for sono-metabolic cancer therapy","volume":"17","author":"Yan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2024.117465_bib259","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1039\/D2BM00650B","article-title":"Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy","volume":"10","author":"Tian","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib260","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","article-title":"Reprogramming tumor immune microenvironment (time) and metabolism via biomimetic targeting codelivery of shikonin\/jq1","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2024.117465_bib261","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.apsb.2021.04.006","article-title":"Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis","volume":"11","author":"Yu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.117465_bib262","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102272","article-title":"Dendritic polyglycerol-conjugated gold nanostars for metabolism inhibition and targeted photothermal therapy in breast cancer stem cells","volume":"11","author":"Pan","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2024.117465_bib263","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/acsnano.1c10231","article-title":"A metabolic multistage glutathione depletion used for tumor-specific chemodynamic therapy","volume":"16","author":"Huang","year":"2022","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib264","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1007\/s12274-022-4237-2","article-title":"Dual inhibition of glycolysis and oxidative phosphorylation by aptamer-based artificial enzyme for synergistic cancer therapy","volume":"15","author":"Fang","year":"2022","journal-title":"Nano Res."},{"key":"10.1016\/j.biopha.2024.117465_bib265","doi-asserted-by":"crossref","first-page":"25365","DOI":"10.1002\/anie.202109258","article-title":"Smart tumor-cell-derived microparticles provide on-demand photosensitizer synthesis and hypoxia relief for photodynamic therapy","volume":"60","author":"Zuo","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.117465_bib266","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/WNR.0000000000001386","article-title":"Selenium nanoparticles reduce glucose metabolism and promote apoptosis of glioma cells through reactive oxygen species-dependent manner","volume":"31","author":"Xu","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2024.117465_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121523","article-title":"Oga activated glycopeptide-based nano-activator to activate pkm2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance","volume":"284","author":"Hou","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib268","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.apsb.2021.12.001","article-title":"Co-delivery of photosensitizer and diclofenac through sequentially responsive bilirubin nanocarriers for combating hypoxic tumors","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.117465_bib269","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2024.117465_bib270","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.134781","article-title":"Zinc-enriched nanosystem for dual glycolysis regulation and photothermal therapy to synergistically inhibit primary melanoma and lung metastasis","volume":"435","author":"Meng","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biopha.2024.117465_bib271","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1021\/acsnano.0c01350","article-title":"3-bromopyruvate-conjugated nanoplatform-induced pro-death autophagy for enhanced photodynamic therapy against hypoxic tumor","volume":"14","author":"Deng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2024.117465_bib272","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002746","article-title":"Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer","volume":"8","author":"Sun","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib273","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.7150\/thno.67543","article-title":"Mitochondrion-targeted supramolecular \u201cnano-boat\u201d simultaneously inhibiting dual energy metabolism for tumor selective and synergistic chemo-radiotherapy","volume":"12","author":"Gao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.117465_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107102","article-title":"Nanoparticles and sirna: a new era in therapeutics?","volume":"201","author":"P\u00e9rez-Carri\u00f3n","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib275","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/1389200219666180918111528","article-title":"Cancer nanotechnology: a new revolution for cancer diagnosis and therapy","volume":"20","author":"Chaturvedi","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2024.117465_bib276","first-page":"1","article-title":"Applications of nanotechnology in cancer: a literature review of imaging and treatment","volume":"5","author":"Bhandare","year":"2014","journal-title":"J. Nucl. Med Radiat. Ther."},{"key":"10.1016\/j.biopha.2024.117465_bib277","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.biotechadv.2012.08.005","article-title":"Nanoencapsulation of polyphenols for protective effect against colon\u2013rectal cancer","volume":"31","author":"Santos","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2024.117465_bib278","doi-asserted-by":"crossref","first-page":"228","DOI":"10.20892\/j.issn.2095-3941.2017.0052","article-title":"Recent progress on nanoparticle-based drug delivery systems for cancer therapy","volume":"14","author":"Xin","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib279","doi-asserted-by":"crossref","unstructured":"Ma Y.-Y., Jin K.-T., Wang S.-B., Wang H.-J., Tong X.-M., Huang D.-S., et al. Molecular imaging of cancer with nanoparticle-based theranostic probes. Contrast media & molecular imaging 2017;2017.","DOI":"10.1155\/2017\/1026270"},{"key":"10.1016\/j.biopha.2024.117465_bib280","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1021\/acsnano.7b07252","article-title":"Big potential from small agents: nanoparticles for imaging-based companion diagnostics","volume":"12","author":"Ehlerding","year":"2018","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib281","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/s100100428","article-title":"Nanotechnology for early cancer detection","volume":"10","author":"Choi","year":"2010","journal-title":"Sensors"},{"key":"10.1016\/j.biopha.2024.117465_bib282","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ultrasmedbio.2019.11.007","article-title":"Seeing the invisible\u2014ultrasound molecular imaging","volume":"46","author":"Kosareva","year":"2020","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.biopha.2024.117465_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100990","article-title":"Selective trafficking of light chain-conjugated nanoparticles to the kidney and renal cell carcinoma","volume":"35","author":"Ordikhani","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2024.117465_bib284","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"A. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","author":"Muz","year":"2015","journal-title":"Hypoxia"},{"key":"10.1016\/j.biopha.2024.117465_bib285","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117465_bib286","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2174\/0929867322666150209151851","article-title":"Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance","volume":"22","author":"Gao","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117465_bib287","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biomaterials.2017.09.008","article-title":"Cuprous oxide nanoparticles trigger er stress-induced apoptosis by regulating copper trafficking and overcoming resistance to sunitinib therapy in renal cancer","volume":"146","author":"Yang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib288","series-title":"In: Animal models in cancer drug discovery","first-page":"75","article-title":"Imaging tools to enhance animal tumor models for cancer research and drug discovery","author":"Alsaab","year":"2019"},{"key":"10.1016\/j.biopha.2024.117465_bib289","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.24791","article-title":"Gene therapies for cancer: strategies, challenges and successes","volume":"230","author":"Das","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2024.117465_bib290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-46","article-title":"Comparisons of three polyethyleneimine-derived nanoparticles as a gene therapy delivery system for renal cell carcinoma","volume":"9","author":"Xu","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib291","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15171\/jrip.2017.20","article-title":"Effects of radiofrequency radiation in the presence of gold nanoparticles for the treatment of renal cell carcinoma","volume":"6","author":"Nikzad","year":"2017","journal-title":"J. Ren. Inj. Prev."},{"key":"10.1016\/j.biopha.2024.117465_bib292","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.phrs.2016.10.016","article-title":"Nanoparticles for cancer gene therapy: recent advances, challenges, and strategies","volume":"114","author":"Wang","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib293","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/pharmaceutics16010031","article-title":"Cancer immunotherapy with lipid nanoparticles loaded with a stimulator of interferon genes agonist against renal tumor lung metastasis","volume":"16","author":"Nakamura","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib294","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1039\/D3TB00308F","article-title":"Next-generation materials for rna\u2013lipid nanoparticles: lyophilization and targeted transfection","volume":"11","author":"Wang","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biopha.2024.117465_bib295","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000002604.05","article-title":"Pd43-05 a novel sirna-based nanotherapy against metastatic clear cell renal cell carcinoma","volume":"207","author":"Rudzinski","year":"2022","journal-title":"J. Urol."},{"key":"10.1016\/j.biopha.2024.117465_bib296","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.001","article-title":"Manipulating the function of tumor-associated macrophages by sirna-loaded lipid nanoparticles for cancer immunotherapy","volume":"325","author":"Shobaki","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib297","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1248\/bpb.b22-00317","article-title":"Development of sirna delivery system by lipid nanoparticles modified with functional materials for cancer treatment","volume":"45","author":"Sakurai","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2024.117465_bib298","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/15583724.2022.2106490","article-title":"Material design for next-generation mrna vaccines using lipid nanoparticles","volume":"63","author":"Higuchi","year":"2023","journal-title":"Polym. Rev."},{"key":"10.1016\/j.biopha.2024.117465_bib299","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/pharmaceutics14030512","article-title":"Nonviral delivery systems of mrna vaccines for cancer gene therapy","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib300","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/cac2.12366","article-title":"Current updates of crispr\/cas9-mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management","volume":"42","author":"Allemailem","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib301","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.biochi.2016.06.007","article-title":"Lncrna in the liver: prospects for fundamental research and therapy by rna interference","volume":"131","author":"Smekalova","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2024.117465_bib302","first-page":"239","article-title":"Non-coding rnas: Recent advancements in the development and biochemistry as novel anti-tumor drug molecules","author":"Nisar","year":"2023","journal-title":"Curr. Stud. HEALTH LIFE Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib303","article-title":"Solid lipid nanoparticles: vital characteristics and prospective applications in cancer treatment","volume":"36","author":"Laz\u0103r","year":"2019","journal-title":"Crit. Rev. \u2122 Ther. Drug Carr. Syst."},{"key":"10.1016\/j.biopha.2024.117465_bib304","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1039\/C7NR09612G","article-title":"Recent advances in anti-angiogenic nanomedicines for cancer therapy","volume":"10","author":"Bhattarai","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117465_bib305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12951-022-01761-7","article-title":"Nanomedicine for renal cell carcinoma: imaging, treatment and beyond","volume":"21","author":"Wu","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113974","article-title":"Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles","volume":"178","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117465_bib307","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.3390\/cancers12123630","article-title":"Silencing of vegfr2 by rgd-modified lipid nanoparticles enhanced the efficacy of anti-pd-1 antibody by accelerating vascular normalization and infiltration of t cells in tumors","volume":"12","author":"Cho","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117465_bib308","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.912594","article-title":"Nanodrugs targeting t cells in tumor therapy","volume":"13","author":"Haist","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117465_bib309","first-page":"1655","article-title":"Broadening the message: a nanovaccine co-loaded with messenger rna and \u03b1-galcer induces antitumor immunity through conventional and natural killer t cells","volume":"13","author":"Verbeke","year":"2019","journal-title":"ACS nano"},{"key":"10.1016\/j.biopha.2024.117465_bib310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.134145","article-title":"Recent advance in nanomaterials for cancer immunotherapy","volume":"435","author":"Hou","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.biopha.2024.117465_bib311","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/pharmaceutics14112285","article-title":"Immunotherapeutic implications of toll-like receptors activation in tumor microenvironment","volume":"14","author":"Zheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib312","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/pharmaceutics16050644","article-title":"Lipid nanoparticles in lung cancer therapy","volume":"16","author":"Omidian","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib313","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12951-022-01626-z","article-title":"Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer","volume":"20","author":"Yadav","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib314","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/pharmaceutics14040866","article-title":"Emerging nanotherapeutic approaches to overcome drug resistance in cancers with update on clinical trials","volume":"14","author":"Bukhari","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117465_bib315","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12032-023-02104-8","article-title":"Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm","volume":"40","author":"Javed","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2024.117465_bib316","unstructured":"Asoudeh M. Elucidating mammalian cellular responses to the uptake of nanoparticles (nps), pathogens, and lipoproteins: Similarities and differences. 2022."},{"key":"10.1016\/j.biopha.2024.117465_bib317","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106732","article-title":"Hmga2 regulation by mirnas in cancer: affecting cancer hallmarks and therapy response","volume":"190","author":"Hashemi","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.117465_bib318","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"Mirna-based biomarkers, therapies, and resistance in cancer","volume":"16","author":"He","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2024.117465_bib319","series-title":"In: Lipid nanocarriers for drug targeting","first-page":"313","article-title":"Lipid-based nanoparticles for cancer treatment","author":"Obeid","year":"2018"},{"key":"10.1016\/j.biopha.2024.117465_bib320","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.nano.2018.05.021","article-title":"Lipid based nanocarriers: a translational perspective","volume":"14","author":"Mishra","year":"2018","journal-title":"Nanomed.: Nanotechnol., Biol. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib321","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.3390\/nano10071424","article-title":"Lipid-based drug delivery nanoplatforms for colorectal cancer therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2024.117465_bib322","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114234","article-title":"Rna-encapsulating lipid nanoparticles in cancer immunotherapy: from pre-clinical studies to clinical trials","volume":"197","author":"Hsia","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2024.117465_bib323","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2018.01.016","article-title":"Recent trends of nanomedicinal approaches in clinics","volume":"538","author":"Dilnawaz","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2024.117465_bib324","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/anie.200802585","article-title":"Nanomedicine\u2014challenge and perspectives","volume":"48","author":"Riehemann","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biopha.2024.117465_bib325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117465_bib326","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.nano.2015.12.377","article-title":"Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model","volume":"12","author":"Jackman","year":"2016","journal-title":"Nanomed.: Nanotechnol.\u00a0Biol. Med."},{"key":"10.1016\/j.biopha.2024.117465_bib327","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbrc.2015.06.177","article-title":"Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs","volume":"468","author":"Szebeni","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib328","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117465_bib329","doi-asserted-by":"crossref","first-page":"15175","DOI":"10.1039\/C5NR03119B","article-title":"A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?","volume":"7","author":"Dreifuss","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2024.117465_bib330","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.117465_bib331","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2024.117465_bib332","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fphar.2018.00228","article-title":"Risk assessment and risk minimization in nanomedicine: a need for predictive, alternative, and 3rs strategies","volume":"9","author":"Accomasso","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117465_bib333","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/17425247.2016.1244187","article-title":"Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures","volume":"14","author":"Ragelle","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib334","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jconrel.2024.06.013","article-title":"Transdermal gene delivery","volume":"371","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.117465_bib335","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/ph11040118","article-title":"Lipid nanoparticles and their hydrogel composites for drug delivery: a review","volume":"11","author":"Desfran\u00e7ois","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2024.117465_bib336","article-title":"Transferosomes as a transdermal drug delivery system: Dermal kinetics and recent developments","volume":"16","author":"Matharoo","year":"2024","journal-title":"Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2024.117465_bib337","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/17425247.2019.1669558","article-title":"Lipid-based nanoparticle formulations for small molecules and rna drugs","volume":"16","author":"Ickenstein","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib338","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425247.2012.673278","article-title":"Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery","volume":"9","author":"Battaglia","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib339","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1055\/s-0042-1751036","article-title":"Lipid-based nanocarrier systems for drug delivery: advances and applications","volume":"4","author":"Zhao","year":"2022","journal-title":"Pharm. Fronts"},{"key":"10.1016\/j.biopha.2024.117465_bib340","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-814031-4.00003-9","article-title":"Lipid-based nanoparticles for drug delivery systems","author":"Samimi","year":"2019","journal-title":"Charact. Biol. Nanomater. Drug Deliv."},{"key":"10.1016\/j.biopha.2024.117465_bib341","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.7150\/thno.77259","article-title":"Lipid nanoparticles for delivery of rna therapeutics: current status and the role of in vivo imaging","volume":"12","author":"Jung","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.117465_bib342","unstructured":"Cheng J., Jian L., Chen Z., Li Z., Yu Y., Wu Y. In vivo delivery processes and development strategies of lipid nanoparticles. ChemBioChem:e202400481."},{"key":"10.1016\/j.biopha.2024.117465_bib343","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"10.1016\/j.biopha.2024.117465_bib344","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acs.jpclett.1c03898","article-title":"Opportunities and challenges for mrna delivery nanoplatforms","volume":"13","author":"Zhang","year":"2022","journal-title":"J. Phys. Chem. Lett."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:57:09Z","timestamp":1778543829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":344,"alternative-id":["S0753332224013519"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117465","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117465"}}